Research and innovation carried out for the handling of Covid-19 are expected to be mass produced in the near future.
AHAD NEWS ■ The efforts of the Ministry of Research and Technology or the National Research and Innovation Agency related to the development of PCR test kits, non-PCR diagnostic test kits, ventilators, and mobile laboratory units with bio safety level (BSL) 2 must be fully supported. Later, the development is targeted to be able to go through the mass production process in the near future.
"I ask that the innovations that have been made, we can start mass production so that we do not depend on imported products from other countries. We hope we can produce at least the end of May or early June, "said President Joko Widodo when leading a limited meeting on the acceleration of the handling of the Covid-19 pandemic by teleconference from the Merdeka Palace, Jakarta, on Monday, May 11, 2020.
The president also received news of rapid progress in blood plasma testing which will later be carried out large-scale clinical trials in several hospitals. Testing using blood plasma from a recovered Covid patient is one of a number of attempts to find the right formula to treat Covid-19. In addition, stem cell (stem cell) testing is also carried out to seek repair of lung tissue damaged by Covid-19.
"Significant progress has also been made in genome sequencing research. This is a very important step to go to the next stage to find a vaccine that is suitable for our country, "added the President.
The Head of State then asked all parties to be able to support the research and innovation. In addition, the President asked his staff to support research and innovation with a quick licensing process and connect the results of research that has been verified with both SOE and private industries. (Red / sif / BPMI Setpres)